Fulminant bilateral haemophilus influenzae keratitis in a patient with hypovitaminosis A treated with contaminated autologous serum

Clinical Ophthalmology

Volumn 5, Issue 1, 2011, Pages 71-73

  Sanz Marco, Empar ^a   Lopez Prats, Maria J ^a   Garcia Delpech, Salvador ^a,d   Udaondo, Patricia ^a   Diaz Llopis, Manuel ^a,b,c  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^d UNIVERSIDAD CATÓLICA DE VALENCIA SAN VICENTE MÁRTIR   (Spain)

Author keywords

Bilateral infectious ulcers; Haemophilus influenzae; Hypovitaminosis a

Indexed keywords

ARTIFICIAL TEAR; CEFTAZIDIME; LINEZOLID; RETINOL; VANCOMYCIN;

ADULT; ALCOHOLISM; ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOLOGOUS SERUM; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; CACHEXIA; CASE REPORT; CLINICAL FEATURE; CORNEA DISEASE; DISEASE SEVERITY; DRUG DOSE INCREASE; HAEMOPHILUS INFLUENZAE; HUMAN; KERATITIS; MALE; NONHUMAN; PERFORATING EYE INJURY; RETINOL DEFICIENCY; SERUM; STAPHYLOCOCCUS EPIDERMIDIS; ULCER; VISUAL ACUITY; VISUAL IMPAIRMENT; WOUND HEALING; XEROPHTHALMIA;

EID: 79251562152     PISSN: 11775467     EISSN: 11775483     Source Type: Book Series    
DOI: 10.2147/OPTH.S15847     Document Type: Article

References (14)

1. Yang KS, Lin HC, Ma DH, et al. Ulcerative keratitis caused by Haemophilus influenzae. Cornea. 2006;25(6):701-704.
2. Asbell P, Stenson S. Ulcerative keratitis: survey of 30 years' laboratory experience. Arch Ophthalmol. 1982;100(1):77-80.
3. Yoder DM, Scott IU, Flynn HW Jr, Miller D. Endophtalmitis caused by Haemophilus Influenzae. Ophtalmology. 2004;111(11):2023-2026.
4. Soukiasian SH, Baum J. Bacterial conjunctivitis. In: Krachmer JH, Mannis MJ, Holland EJ, editors. Cornea. St. Louis, MO: Mosby;1997: 759-771.
5. Sykes SO, Riemann C, Santos CI, et al. Haemophilus influenzae associated scleritis. Br J Ophthalmol. 1999;83(4):410-413.
6. Tsubota K, Higuchi A. Serum application for the treatment of ocular surface disorders. Int Ophthalmol Clin. 2000(4);113-122.
7. Geerling G, Maclennan, Hartwig D. Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol. 2004;88(11):1467-1474.
8. Tsubota K, Goto E, Fujita H, et al. Treatment of dry eye by autologous serum application in Sjögren's Syndrome. Br J Ophthalmol. 1999;83(4): 390-395.
9. Tsubota K, Goto E, Shimmura S, Shimazaki J. Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology. 1999;106(10):1984-1989.
10. Bosch-Valero J, Martín-Aviá J, Sierra-Barreras J, et al. Use of autologous serum in hypovitaminosis-induced ocular pathology. Arch Soc Esp Oftalmol. 2008;83(1):45-48.
11. Lagnado R, King AJ, Donald F, Dua HS. A protocol for low contamination risk of autologous serum drops in the management of ocular surface disorders. Br J Ophthalmol. 2004;88(4):464-465.
12. Tananuvat N, Daniell M, Sullivan LJ, et al. Controlled study of the use of autologous serum in dry eye patients. Cornea. 2001;20(8):802-806.
13. Amaral JF, Foschetti DA, Assis FA, Menezes JS, Vaz NM, Faria AM. Immunoglobulin production is impaired in protein-deprived mice and can be restored by dietary protein supplementation. Braz J Med Biol Res. 2006;39(12):1581-1586.
14. Cartwright CP, Stock F, Gill VJ. Improved enrichment broth for cultivation of fastidious organisms. J Clin Microbiol. 1994;32(7):1825-1826.